Latest From Biotech Now

WSJ: The Measles Outbreak Coming Near You

Wall Street Journal

We’ve written before about the disturbing rise in the prevalence of diseases that, thanks to vaccines, had once been considered eradicated or near-eradicated in the US. In today’s Wall Street Journal, Dr. Haider Javed Warraich, a physician at the Beth Israel Deaconess Medical Center in Boston and an instructor at Harvard Medical School, discusses the problem in depth: Measles is making a terrifying comeback in the U.S., with some 600 cases reported this year, more Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

patent

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase prices, but does ensure widespread access to life saving therapeutics. This research confirms that a weak patent environment slows drug availability and hinders treatment to many people in need. Data Shows Little Change in Indian Drug Prices after Implementing Stronger Patent System In a new report published by the National Bureau of Economic Research, scholars found that patented drugs did not Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

BIO and Affiliates Highlight the Growing Biorenewables Sector in California

Pac_Rim115x75

In 2013, California’s life science industry created almost $259 billion in economic activity for the state. The biorenewables sector was instrumental in generating this growth, creating high-paying jobs and attractive economic opportunities for investors.  In a recent release, BIO and its California state affiliates, BayBio and Biocom, highlighted how the biorenewbales sector have helped grow California’s bioeconomy: “California’s flourishing industrial biotech sector makes the region an ideal location to hold discussions about the future of the Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Exclusive FDA Survey Webinar

medical_research

BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development.  We are excited to announce an exclusive webinar for survey participants only to reveal the preliminary results of the study.  Participants are invited to attend this webinar to gain exclusive access to survey insights and hear analysis of the survey data from regulatory experts, including FDA staff. This exciting webinar opportunity is scheduled for Wednesday, January 28 at 1:00 pm Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Voting Now Open for the Buzz of BIO at the 2015 BIO CEO & Investor Conference

CEO-BuzzofBIO

The Buzz of BIO contest at the 2015 BIO CEO & Investor Conference recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Voting has officially opened for the below companies nominated in each of two categories – Most Distinguished Public Company and Most Promising Private Company. Winners will receive a complimentary company presentation and individual registration, plus promotion by BIO and BioCentury. The Most Distinguished Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,